Susanna Brighenti

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: IMMUNOBIOLOGY. 2023;228(2):152350

Immune cell landscape in symptomatic and asymptomatic SARS-CoV-2 infected adults and children in urban Dhaka, Bangladesh.

Akhtar E; Mily A; Sarker P; Chanda BC; Haque F; Kuddusi RU; Haq MA; Lourda M; Brighenti S; Raqib R
Article: RESPIRATORY RESEARCH. 2023;24(1):62

Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia.

Palma Medina LM; Babačić H; Dzidic M; Parke Å; Garcia M; Maleki KT; Unge C; Lourda M; Kvedaraite E; Chen P; Muvva JR; Cornillet M; Emgård J; Moll K; Karolinska K. I./K. COVID-19 Study Group; Michaëlsson J; Flodström-Tullberg M; Brighenti S; Buggert M; Mjösberg J; Malmberg K-J; Sandberg JK; Gredmark-Russ S; Rooyackers O; Svensson M; Chambers BJ; Eriksson LI; Pernemalm M; Björkström NK; Aleman S; Ljunggren H-G; Klingström J; Strålin K; Norrby-Teglund A
Journal article: FRONTIERS IN IMMUNOLOGY. 2023;14:1296501

Inflammatory immune profiles associated with disease severity in pulmonary tuberculosis patients with moderate to severe clinical TB or anemia.

Ashenafi S; Loreti MG; Bekele A; Aseffa G; Amogne W; Kassa E; Aderaye G; Brighenti S
Article: MBIO. 2022;13(5):e0108622-e01022

High Glucose and Carbonyl Stress Impair HIF-1-Regulated Responses and the Control of Mycobacterium tuberculosis in Macrophages.

Terán G; Li H; Catrina S-B; Liu R; Brighenti S; Zheng X; Grünler J; Nylén S; Carow B; Rottenberg ME
Article: NUTRIENTS. 2022;14(16):3318

Anemia Is a Strong Predictor of Wasting, Disease Severity, and Progression, in Clinical Tuberculosis (TB).

Ashenafi S; Bekele A; Aseffa G; Amogne W; Kassa E; Aderaye G; Worku A; Bergman P; Brighenti S
Article: AMERICAN JOURNAL OF PATHOLOGY. 2022;192(4):653-670

Immunosuppressive Features of the Microenvironment in Lymph Nodes Granulomas from Tuberculosis and HIV-Co-Infected Patients.

Ashenafi S; Muvva JR; Mily A; Snäll J; Zewdie M; Chanyalew M; Rehn A; Rahman S; Aseffa G; Bekele A; Aderaye G; Lema B; Svensson M; Brighenti S
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021;118(40):e2109123118

High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.

Lourda M; Dzidic M; Hertwig L; Bergsten H; Palma Medina LM; Sinha I; Kvedaraite E; Chen P; Muvva JR; Gorin J-B; Cornillet M; Emgård J; Moll K; García M; Maleki KT; Klingström J; Michaëlsson J; Flodström-Tullberg M; Brighenti S; Buggert M; Mjösberg J; Malmberg K-J; Sandberg JK; Henter J-I; Folkesson E; Gredmark-Russ S; Sönnerborg A; Eriksson LI; Rooyackers O; Aleman S; Strålin K; Ljunggren H-G; Björkström NK; Svensson M; Ponzetta A; Norrby-Teglund A; Chambers BJ; Karolinska KI/K COVID-19 Study Group
Article: JOURNAL OF INFECTIOUS DISEASES. 2021;224(2):332-344

Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity.

Rao Muvva J; Ahmed S; Rekha RS; Kalsum S; Groenheit R; Schön T; Agerberth B; Bergman P; Brighenti S
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021;118(6):e2018587118

Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.

Kvedaraite E; Hertwig L; Sinha I; Ponzetta A; Hed Myrberg I; Lourda M; Dzidic M; Akber M; Klingström J; Folkesson E; Muvva JR; Chen P; Gredmark-Russ S; Brighenti S; Norrby-Teglund A; Eriksson LI; Rooyackers O; Aleman S; Strålin K; Ljunggren H-G; Ginhoux F; Björkström NK; Henter J-I; Svensson M; Karolinska KI/K COVID-19 Study Group
Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2021;10(7):e1306

SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.

Sandberg JT; Varnaitė R; Christ W; Chen P; Muvva JR; Maleki KT; García M; Dzidic M; Folkesson E; Skagerberg M; Ahlén G; Frelin L; Sällberg M; Eriksson LI; Rooyackers O; Sönnerborg A; Buggert M; Björkström NK; Aleman S; Strålin K; Klingström J; Ljunggren H-G; Blom K; Gredmark-Russ S; Karolinska COVID‐19 Study Group
Article: BMC INFECTIOUS DISEASES. 2020;20(1):933

Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.

Mily A; Sarker P; Taznin I; Hossain D; Haq MA; Kamal SMM; Agerberth B; Brighenti S; Raqib R
Article: CELL. 2020;183(1):158-168.e14

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.

Sekine T; Perez-Potti A; Rivera-Ballesteros O; Strålin K; Gorin J-B; Olsson A; Llewellyn-Lacey S; Kamal H; Bogdanovic G; Muschiol S; Wullimann DJ; Kammann T; Emgård J; Parrot T; Folkesson E; Karolinska COVID-19 Study Group; Rooyackers O; Eriksson LI; Henter J-I; Sönnerborg A; Allander T; Albert J; Nielsen M; Klingström J; Gredmark-Russ S; Björkström NK; Sandberg JK; Price DA; Ljunggren H-G; Aleman S; Buggert M
Article: SCIENCE IMMUNOLOGY. 2020;5(51):eabe1670

MAIT cell activation and dynamics associated with COVID-19 disease severity.

Parrot T; Gorin J-B; Ponzetta A; Maleki KT; Kammann T; Emgård J; Perez-Potti A; Sekine T; Rivera-Ballesteros O; Karolinska COVID-19 Study Group; Gredmark-Russ S; Rooyackers O; Folkesson E; Eriksson LI; Norrby-Teglund A; Ljunggren H-G; Björkström NK; Aleman S; Buggert M; Klingström J; Strålin K; Sandberg JK
Journal article: JOVE-JOURNAL OF VISUALIZED EXPERIMENTS. 2020;(163)

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection

Mily A; Kalsum S; Loreti MG; Rekha RS; Muvva JR; Lourda M; Brighenti S
Article: JOVE-JOURNAL OF VISUALIZED EXPERIMENTS. 2020;(163)

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection.

Mily A; Kalsum S; Loreti MG; Rekha RS; Muvva JR; Lourda M; Brighenti S
Article: SCIENCE IMMUNOLOGY. 2020;5(50):eabd6832

Natural killer cell immunotypes related to COVID-19 disease severity.

Maucourant C; Filipovic I; Ponzetta A; Aleman S; Cornillet M; Hertwig L; Strunz B; Lentini A; Reinius B; Brownlie D; Cuapio A; Ask EH; Hull RM; Haroun-Izquierdo A; Schaffer M; Klingström J; Folkesson E; Buggert M; Sandberg JK; Eriksson LI; Rooyackers O; Ljunggren H-G; Malmberg K-J; Michaëlsson J; Marquardt N; Hammer Q; Strålin K; Björkström NK; Karolinska COVID-19 Study Group
Article: NUTRIENTS. 2019;11(7):E1675-1675

Vitamin D and Phenylbutyrate Supplementation Does Not Modulate Gut Derived Immune Activation in HIV-1.

Missailidis C; Sørensen N; Ashenafi S; Amogne W; Kassa E; Bekele A; Getachew M; Gebreselassie N; Aseffa A; Aderaye G; Andersson J; Brighenti S; Bergman P
Article: NUTRIENTS. 2019;11(1):E133-133

Daily Nutritional Supplementation with Vitamin D₃ and Phenylbutyrate to Treatment-Naïve HIV Patients Tested in a Randomized Placebo-Controlled Trial.

Ashenafi S; Amogne W; Kassa E; Gebreselassie N; Bekele A; Aseffa G; Getachew M; Aseffa A; Worku A; Hammar U; Bergman P; Aderaye G; Andersson J; Brighenti S
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:3157

Polarization of Human Monocyte-Derived Cells With Vitamin D Promotes Control of Mycobacterium tuberculosis Infection.

Rao Muvva J; Parasa VR; Lerm M; Svensson M; Brighenti S
Article: JOURNAL OF INTERNAL MEDICINE. 2018;284(3):292-306

Daily adjunctive therapy with vitamin D3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia.

Bekele A; Gebreselassie N; Ashenafi S; Kassa E; Aseffa G; Amogne W; Getachew M; Aseffa A; Worku A; Raqib R; Agerberth B; Hammar U; Bergman P; Aderaye G; Andersson J; Brighenti S
Article: NUTRIENTS. 2018;10(6):E721-721

Vitamin D₃ Status and the Association with Human Cathelicidin Expression in Patients with Different Clinical Forms of Active Tuberculosis.

Ashenafi S; Mazurek J; Rehn A; Lemma B; Aderaye G; Bekele A; Assefa G; Chanyalew M; Aseffa A; Andersson J; Bergman P; Brighenti S
Article: RESPIRATORY MEDICINE. 2018;138S:S38-S44

Enhanced CD8+ cytolytic T cell responses in the peripheral circulation of patients with sarcoidosis and non-Löfgren's disease.

Parasa VR; Forsslund H; Enger T; Lorenz D; Kullberg S; Eklund A; Sköld M; Wahlström J; Grunewald J; Brighenti S
Article: FASEB JOURNAL. 2018;32(5):2827-2840

Prostaglandin E2 suppresses hCAP18/LL-37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection.

Wan M; Tang X; Rekha RS; Muvva SSVJR; Brighenti S; Agerberth B; Haeggström JZ
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2017;59:29-36

IL-7δ5 protein is expressed in human tissues and induces expression of the oxidized low density lipoprotein receptor 1 (OLR1) in CD14+ monocytes.

Rane L; Rahman S; Magalhaes I; Ambati A; Andersson J; Zumla A; Brighenti S; Maeurer MJ
Article: VACCINE. 2017;35(12):1652-1661

Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials.

Norrby M; Vesikari T; Lindqvist L; Maeurer M; Ahmed R; Mahdavifar S; Bennett S; McClain JB; Shepherd BM; Li D; Hokey DA; Kromann I; Hoff ST; Andersen P; de Visser AW; Joosten SA; Ottenhoff THM; Andersson J; Brighenti S
Article: FRONTIERS IN MICROBIOLOGY. 2017;8:2370

Inhibition of Tissue Matrix Metalloproteinases Interferes with Mycobacterium tuberculosis-Induced Granuloma Formation and Reduces Bacterial Load in a Human Lung Tissue Model.

Parasa VR; Muvva JR; Rose JF; Braian C; Brighenti S; Lerm M
Article: MICROBIOLOGY SPECTRUM. 2016;4(6)

Regulation of Immunity to Tuberculosis.

Brighenti S; Ordway DJ
Article: ETHIOPIAN MEDICAL JOURNAL. 2016;54(4):181-188

LATENT TUBERCULOSIS AMONG ADULT ETHIOPIAN PATIENTS AT CHEST CLINIC, TIKURANBESSA SPECIALIZED HOSPITAL, ADDIS ABABA, ETHIOPIA.

Bekele A; Ashenafi S; Aderay G; Assefa G; Aseffa A; Anderssen J; Brighenti S
Article: CLINICAL INFECTIOUS DISEASES. 2015;61Suppl 3(Suppl 3):S225-S234

B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis.

Rao M; Valentini D; Poiret T; Dodoo E; Parida S; Zumla A; Brighenti S; Maeurer M
Article: JOVE-JOURNAL OF VISUALIZED EXPERIMENTS. 2015;(104):53084

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection.

Braian C; Svensson M; Brighenti S; Lerm M; Parasa VR
Article: AUTOPHAGY. 2015;11(9):1688-1699

Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages.

Rekha RS; Rao Muvva SSVJ; Wan M; Raqib R; Bergman P; Brighenti S; Gudmundsson GH; Agerberth B
Article: CLINICAL IMMUNOLOGY. 2015;156(2):85-97

Pulmonary tuberculosis patients with a vitamin D deficiency demonstrate low local expression of the antimicrobial peptide LL-37 but enhanced FoxP3+ regulatory T cells and IgG-secreting cells.

Rahman S; Rehn A; Rahman J; Andersson J; Svensson M; Brighenti S
Article: PLOS ONE. 2015;10(9):e0138340

Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial.

Mily A; Rekha RS; Kamal SMM; Arifuzzaman ASM; Rahim Z; Khan L; Haq MA; Zaman K; Bergman P; Brighenti S; Gudmundsson GH; Agerberth B; Raqib R
Article: CLINICAL IMMUNOLOGY. 2014;151(2):84-99

Progression of clinical tuberculosis is associated with a Th2 immune response signature in combination with elevated levels of SOCS3.

Ashenafi S; Aderaye G; Bekele A; Zewdie M; Aseffa G; Hoang ATN; Carow B; Habtamu M; Wijkander M; Rottenberg M; Aseffa A; Andersson J; Svensson M; Brighenti S
Article: DISEASE MODELS & MECHANISMS. 2014;7(2):281-288

Modeling Mycobacterium tuberculosis early granuloma formation in experimental human lung tissue.

Parasa VR; Rahman MJ; Ngyuen Hoang AT; Svensson M; Brighenti S; Lerm M
Article: THORAX. 2013;68(3):269-276

BCG-specific IgG-secreting peripheral plasmablasts as a potential biomarker of active tuberculosis in HIV negative and HIV positive patients.

Ashenafi S; Aderaye G; Zewdie M; Raqib R; Bekele A; Magalhaes I; Lema B; Habtamu M; Rekha RS; Aseffa G; Maeurer M; Aseffa A; Svensson M; Andersson J; Brighenti S
Article: JOURNAL OF INFECTIOUS DISEASES. 2012;205 Suppl 2:S316-S324

Local immune responses in human tuberculosis: learning from the site of infection.

Brighenti S; Andersson J
Article: MOLECULAR MEDICINE. 2012;18(1):647-658

Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates.

Rahman S; Magalhaes I; Rahman J; Ahmed RK; Sizemore DR; Scanga CA; Weichold F; Verreck F; Kondova I; Sadoff J; Thorstensson R; Spångberg M; Svensson M; Andersson J; Maeurer M; Brighenti S
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2012;132(1):114-123

Plasmacytoid dendritic cells infiltrate the skin in positive tuberculin skin test indurations.

Bond E; Liang F; Sandgren KJ; Smed-Sörensen A; Bergman P; Brighenti S; Adams WC; Betemariam SA; Rangaka MX; Lange C; Wilkinson RJ; Andersson J; Loré K
Article: GENES AND IMMUNITY. 2011;12(7):513-522

Increased (6 exon) interleukin-7 production after M. tuberculosis infection and soluble interleukin-7 receptor expression in lung tissue.

Rane L; Rahman S; Magalhaes I; Ahmed R; Spångberg M; Kondova I; Verreck F; Andersson J; Brighenti S; Maeurer MJ
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2010;396(1):50-57

Induction and regulation of CD8+ cytolytic T cells in human tuberculosis and HIV infection.

Brighenti S; Andersson J
Article: AMERICAN JOURNAL OF PATHOLOGY. 2009;174(6):2211-2224

Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesions.

Rahman S; Gudetta B; Fink J; Granath A; Ashenafi S; Aseffa A; Derbew M; Svensson M; Andersson J; Brighenti SG
Article: INFECTION AND IMMUNITY. 2007;75(11):5210-5222

Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis.

Andersson J; Samarina A; Fink J; Rahman S; Grundström S
Article: MICROBES AND INFECTION. 2006;8(8):1985-1993

Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype.

Toro JC; Hoffner S; Linde C; Andersson M; Andersson J; Grundström S
Article: INFECTION AND IMMUNITY. 2005;73(10):6332-6339

Conserved structure and function in the granulysin and NK-lysin peptide family.

Linde CMA; Grundström S; Nordling E; Refai E; Brennan PJ; Andersson M
Article: JOURNAL OF IMMUNOLOGICAL METHODS. 2005;302(1-2):13-25

Detection of human perforin by ELISpot and ELISA: ex vivo identification of virus-specific cells.

Zuber B; Levitsky V; Jönsson G; Paulie S; Samarina A; Grundström S; Metkar S; Norell H; Callender GG; Froelich C; Ahlborg N
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2004;279(9):8460-8468

Bcl-3 and NFkappaB p50-p50 homodimers act as transcriptional repressors in tolerant CD4+ T cells.

Grundström S; Anderson P; Scheipers P; Sundstedt A
Article: JOURNAL OF IMMUNOLOGY. 2003;170(10):5008-5017

Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo.

Grundström S; Cederbom L; Sundstedt A; Scheipers P; Ivars F
Article: JOURNAL OF IMMUNOLOGY. 2000;164(3):1175-1184

IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.

Grundström S; Dohlsten M; Sundstedt A
Article: IMMUNOLOGY. 1998;95(1):76-82

T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.

Sundstedt A; Grundström S; Dohlsten M
Visa fler

Alla övriga publikationer

Review: FRONTIERS IN IMMUNOLOGY. 2022;13:1059725

Reinventing the human tuberculosis (TB) granuloma: Learning from the cancer field.

Ashenafi S; Brighenti S
Corrigendum: JOVE-JOURNAL OF VISUALIZED EXPERIMENTS. 2020;(164)

Erratum: Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection.
Editorial comment: NUTRIENTS. 2020;12(6):E1682-1682

Targeted Nutrition in Chronic Disease.

Bergman P; Brighenti S
Review: FRONTIERS IN MEDICINE. 2020;7:537

Host and Pathogen Communication in the Respiratory Tract: Mechanisms and Models of a Complex Signaling Microenvironment.

Berry SB; Haack AJ; Theberge AB; Brighenti S; Svensson M
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2018;:113-115

Toward the understanding of human tuberculosis.

Brighenti S; Lerm M
Review: JOURNAL OF INTERNAL MEDICINE. 2018;:163-188

Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis.

Lange C; Alghamdi WA; Al-Shaer MH; Brighenti S; Diacon AH; DiNardo AR; Grobbel HP; Gröschel MI; von Groote-Bidlingmaier F; Hauptmann M; Heyckendorf J; Köhler N; Kohl TA; Merker M; Niemann S; Peloquin CA; Reimann M; Schaible UE; Schaub D; Schleusener V; Thye T; Schön T
Review: JOURNAL OF INTERNAL MEDICINE. 2018;:145-162

Vitamin D and tuberculosis: where next?

Brighenti S; Bergman P; Martineau AR
Review: JOURNAL OF INTERNAL MEDICINE. 2018;:125-144

Friends and foes of tuberculosis: modulation of protective immunity.

Brighenti S; Joosten SA
Book chapter: 2017;p. 73-93

Regulation of Immunity to Tuberculosis

Brighenti S; Ordway DJ
Review: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2017;56:140-154

Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccination.

Valentini D; Rao M; Rane L; Rahman S; Axelsson-Robertson R; Heuchel R; Löhr M; Hoft D; Brighenti S; Zumla A; Maeurer M
Review: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2017;56:167-175

Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren's syndrome using high-content peptide microarrays.

Ferrara G; Valentini D; Rao M; Wahlström J; Grunewald J; Larsson L-O; Brighenti S; Dodoo E; Zumla A; Maeurer M
Letter: THORAX. 2011;66(8):727-729

A new potential biomarker for childhood tuberculosis.

Thomas T; Brighenti S; Andersson J; Sack D; Raqib R
Review: CURRENT HIV/AIDS REPORTS. 2006;3(1):32-38

Studies of HIV-associated immune responses in lymphoid compartments.

Grundström S; Andersson J

Forskningsbidrag

Immune profiling and immune checkpoint modulation of multidrug-resistant tuberculosis infection (IPIM)

Swedish Research Council

1 January 2023 - 31 December 2026
Discovery of epigenetic modulators designed to treat and cure different tuberculosis endotypes by improving antimicrobial cellular immunity

Swedish Research Council

1 December 2022 - 30 November 2025
Towards two-step combination treatment with epigenetic- and immune-modulating drugs to promote cure and prevent antibiotic resistance in tuberculosis

Swedish Research Council

1 January 2020 - 31 December 2022
Exploring epigenetic alterations of cellular immunity in multidrug-resistant tuberculosis with relevance for new therapy using epigenetic- and immune-modulating drugs

Swedish Research Council

1 January 2020 - 31 December 2022
Mot två-stegs kombinationsbehandling med preparat som har epigenetiska- och immunmodulerande egenskaper som kan stödja utläkning av samt förhindra utveckling av antibiotika resistent tuberkulos

Swedish Heart-Lung Foundation

1 January 2020 - 31 December 2022
Mot två-stegs kombinationsbehandling med preparat som har epigenetiska- och immunmodulerandeegenskaper som kan stödja utläkning av samt förhindra utveckling av antibiotika resistent tuberkulos

Swedish Heart-Lung Foundation

1 January 2020 - 31 December 2022
10th International Conference on the Pathogenesis of Mycobacterial Infections

Swedish Research Council

1 November 2016 - 30 November 2016
An innovative human lung tissue model for tuberculosis research

Swedish Research Council

1 January 2015 - 31 December 2017
Discovery of immunopathogenesis in human tuberculosis: new concepts for diagnosis and treatment

Swedish Research Council

1 January 2015 - 31 December 2017
The role of diabetes-associated pathology in the development of clinical tuberculosis: a collaborative project between Sweden and Bangladesh

Swedish Research Council

1 January 2015 - 31 December 2018
Innovative human lung tissue model for tuberculosis research

Swedish Research Council

1 January 2013 - 31 December 2014
Novel treatment of infectious diseases via induction of mucosal immunity

Swedish Research Council

1 January 2013 - 31 December 2015
Discovery of pathogenesis in human tuberculosis with novel implications for clinical practise

Swedish Research Council

1 January 2012 - 31 December 2014
8th International Conference on the Pathogenesis of Mycobacterial Infections

Swedish Research Council

1 July 2010 - 31 December 2010
Studies of dysfunctional immunity in HIV disease with implications for immune reconstitution and vaccine development

Swedish Research Council

1 January 2010 - 31 December 2012

Anställningar

Senior Forskare, Immunsvar vid tuberkulos (TB), Medicin, Huddinge, Karolinska Institutet, 2014-

Examina och utbildning

Docent, Immunologi, Karolinska Institutet, 2014

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI